News & Updates

Filter By:
All
News
Press Releases
Events
Videos
Publications

Events | News

Grace Colón Participates in virtual workshop “Innovation in Drug Research and Development for Prevalent Chronic Diseases”

Read More

News

InCarda Therapeutics featured in Men’s Health

Read More

News | Press Releases

InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation

Read More

Events | News

InCarda’s CEO Grace Colon participated in a panel discussion at Biotech Showcase 2021 on January 11, 2021

Read More

News

Grace Colón Joins the First Rounders Podcast

Read More

Events | News

Grace Colón & Jeff Ho Join FIRESIDE chat with Umer Raffat & Michael DiFiore

Read More

Events | News

InCarda Therapeutics to Present Preliminary Phase 2 Data at American Heart Association 2020 Scientific Sessions (Nov. 13-17, 2020)

Read More

Press Releases

InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020

Read More

News

InCarda Therapeutics featured in Endpoints News

Read More

Press Releases

InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing

Read More

News

InCarda Therapeutics featured in FierceBiotech News

Read More

Events | News

Grace Colón Joins Panel Discussion Regarding Diversity and Inclusion During BIO Investor Forum Digital 2020

Read More

Tweets by InCardaThera

Clinical Announcement

InCarda Therapeutics Recruiting for Phase 2 Clinical Trial in PAF

Read More